Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Drug 'more effective than Prozac'

  • Comment

A new drug could offer hope to sufferers of depression after research revealed it is more effective than Prozac in treating the condition.

Patients from the UK have taken part in the study which found that agomelatine (Valdoxan) helped 77.7% of people with severe depression, compared with 68.8% on Prozac - one of the most common anti-depressants.

There are also thought to be fewer side-effects from agomelatine, which can include weight gain, sexual problems and difficulty sleeping.

Previous research has shown that, in the first week of treatment, agomelatine, which costs £30 a month to prescribe, works in twice as many people compared to another antidepressant, venlafaxine (Efexor).

The latest was carried out on 515 patients with an average age of 42, who were followed for eight weeks, the European Congress of Neuropsychopharmacology in Istanbul heard.

Lead researcher Professor Tony Hale, head of division of psychiatry at the University of Kent, said the results ‘add to the growing wealth of evidence supporting agomelatine as a new and important alternative for the treatment of depression’.


  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs